Consistent with our findings, previous studies have shown that Acox2−/− mice, exhibiting clinical signs of NAFLD, displayed significantly reduced blood and liver levels of 1-MNAM and NNMT expression (Zhang et al. 2021). This evidence concerns the gene NNMT and metabolic dysfunction-associated steatotic liver disease.